PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Public Health Services, Jerusalem, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.\', \'Pfizer, Collegeville, PA, USA.\', \'Public Health Services, Jerusalem, Israel; Hadassah Braun School of Public Health, Faculty of Medicine, Hebrew University, Jerusalem, Israel.\', \'Faculty of Medicine Harvard T H Chan School of Public Health, Boston, MA, USA.\', \'Pfizer Pharmaceuticals Israel, Herzliya, Israel.\', \'Information Technology Department, Israel Ministry of Health, Jerusalem, Israel.\', \'Israel Ministry of Health, Jerusalem, Israel.\', \'Public Health Services, Jerusalem, Israel. Electronic address: sharon.alroy@moh.gov.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1473-3099(21)00566-110.1016/S1473-3099(21)00566-1
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34562375
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all